Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 23
- Markets & Stocks
European Cannabis Stocks Review: FSA Makes ‘Final Call’ For Evidence As Cellular Goods’ Stock Recovers From Confusion Over Its Products’ Inclusion
THE fallout from the publication of the FSA’s Public List is continuing to be felt on the stock markets this week, with the regulator issuing a ‘final call’ for evidence after a number of CBD companies came forward with ‘new evidence linking large numbers of individual products to applications.’
- Markets & Stocks
EU Cannabis Stocks Review: SEED Innovations Eurox Investment Bears Fruit, Akanda Continues To Climb & Intercure Posts Record Figures
Despite a number of positive announcements coming from the UK this week, British cannabis stocks failed to match the dramatic upswings experienced by their US counterparts.
- Pharmaceutical
Celadon Becomes First UK Cannabis Company To Be Admitted To AIM In 21 Years
CELADON Pharmaceuticals successfully listed on the Alternative Investments Market (AIM) this week, making it the first British company to join in 21 years.
- Markets & Stocks
EU Cannabis Stocks Review: Board Changes At Kanabo & Cellular Goods, Panaxia Stages Comeback & Akanda Continues Rally
European cannabis stocks had another generally positive week last week, with some major announcements from the North American market prop-up gains across the continent.
- Markets & Stocks
EU Cannabis Stocks Review: Cellular Goods Stock Jumps 50% After Marketing Campaign Launch, SEED Innovations Enjoys Recovery, More from DeepVerge & Akanda
FOLLOWING a difficult few weeks for European cannabis stocks, last week saw many enjoy a recovery amid a flurry of positive announcements from both the industry and individual companies.
- Pharmaceutical
EU Cannabis Stocks Review: OCT Board Accused of Serious Governance Issues by Co-Founder, Panaxia’s Debt Pile Hits Stock & More from Love Hemp
AS European Cannabis stocks continue their battle against external market forces, it has been internal battles which made the headlines this week.
- Pharmaceutical
One Year After The First Cannabis Stocks Joined The LSE, Could We See A Fresh Run Of Cannabis IPOs This Year?
FEBRUARY 2022 marked the one-year anniversary of MGC Pharmaceuticals IPO on the London Stock Exchange, which saw cannabis stocks traded on the platform for the first time in its 320-year history.
- Markets & Stocks
EU Cannabis Stocks Review: How Ukraine Crisis Is Impacting Cannabis Stocks, Chill Brands’ Revenue Could Be $1m Less & More From Tilray and MGC Pharma
LAST week began with a number of European cannabis stocks levelling out following dramatic declines days earlier in reaction to Russia’s invasion of Ukraine.
- Markets & Stocks
Update on the Republican legalization bill
REPUBLICAN BILL GOP cannabis legalization bill will be heard by Congress: Mace In an interview on the Psychoactive podcast with Drug Policy Alliance founder Ethan Nadelmann, Republican Rep.
- Cultivation
Two producers teaming up better than one?
TEAMWORK = DREAMWORK? HEXO and Tilray announce plans to team up After restructuring its board earlier this year and appointing a new CEO last fall, Canadian producer HEXO may have found a way to manage its debt problem, too.
- Pharmaceutical
Summerway Capital Returns To AIM To Fund £80m Take-Over Of UK Cannabis Cultivator
SUMMERWAY Capital’s (LON: SWC) £80m reverse takeover of one of the UK’s few licenced high-THC cannabis growers has seen it relaunch its shares on the London Stock Exchange (LSE) in order to fund its new acquisition.
